You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 98 No. 5, NOVEMBER 1956 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Psychosomatic Problem in Drug Evaluation

The Importance of Studying Pharmacodynamics and Establishing Effective Dosage Schedules

JOHN H. MOYER, M.D.

AMA Arch Intern Med. 1956;98(5):608-616.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

If a new drug is to be studied properly the investigation must be approached systematically. After adequate laboratory observations have been completed, the most important studies required are those related to clinical pharmacodynamics and probable therapeutic applications. It is after these studies have been completed that an attempt should be made to quantitate therapeutic results, utilizing such methods as doubleblind studies, and then only in those indications where the drug appears to be of therapeutic value. After all, it is pointless to study a drug, using a double-blind technique or any other method, if initial screening studies indicate that the drug has little or no therapeutic value within a safe, tolerable dosage range.

Double-blind studies are most useful for evaluating the effects of drugs that are only moderately potent and notably when objective tests of therapeutic efficacy are not available. This is particularly true of drugs used by the neuropsychiatrist, . . . [Full Text PDF of this Article]


Author Affiliations

Houston, Texas

Departments of Pharmacology and Medicine Baylor University College of Medicine.


Footnotes

Received for publication March 16, 1956.

Presented before the Academy of Psychosomatic Medicine, New York City, 1955.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1956 American Medical Association. All Rights Reserved.